0001209191-16-129450.txt : 20160624
0001209191-16-129450.hdr.sgml : 20160624
20160624082140
ACCESSION NUMBER: 0001209191-16-129450
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20160615
FILED AS OF DATE: 20160624
DATE AS OF CHANGE: 20160624
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CELGENE CORP /DE/
CENTRAL INDEX KEY: 0000816284
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 222711928
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
BUSINESS PHONE: (908)673-9000
MAIL ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: VESSEY RUPERT
CENTRAL INDEX KEY: 0001677618
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34912
FILM NUMBER: 161729932
MAIL ADDRESS:
STREET 1: C/O CELGENE CORPORATION
STREET 2: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2016-06-15
0
0000816284
CELGENE CORP /DE/
CELG
0001677618
VESSEY RUPERT
C/O CELGENE CORPORATION
86 MORRIS AVENUE
SUMMIT
NJ
07901
0
1
0
0
See remarks
Common Stock
3650
D
Common Stock
135
I
401(k) Plan
Stock Option (right to buy)
118.57
2025-02-02
Common Stock
19142
D
Stock Option (right to buy)
109.90
2025-05-04
Common Stock
3125
D
Stock Option (right to buy)
132.56
2025-07-27
Common Stock
3125
D
Stock Option (right to buy)
114.08
2025-11-09
Common Stock
3125
D
Stock Option (right to buy)
100.80
2026-02-01
Common Stock
3125
D
Stock Option (right to buy)
104.97
2026-05-02
Common Stock
12906
D
Restricted Stock Unit
Common Stock
11246
D
Restricted Stock Unit
Common Stock
781
D
Restricted Stock Unit
Common Stock
5350
D
Restricted Stock Unit
Common Stock
6731
D
The option was issued pursuant to the Company's 2008 Stock Incentive Plan (as amended and restated as of April 15, 2015).
The option is immediately exercisable and will vest in four equal annual installments commencing on February 2, 2016.
The option is immediately exercisable and will vest in four equal annual installments commencing on May 4, 2016.
The option is immediately exercisable and will vest in four equal annual installments commencing on July 27, 2016.
The option is immediately exercisable and will vest in four equal annual installments commencing on November 9, 2016.
The option is immediately exercisable and will vest in four equal annual installments commencing on February 1, 2017.
The option is immediately exercisable and will vest in four equal annual installments commencing on May 2, 2017.
The restricted stock units will vest in two annual installments as follows: 5,622 shares on February 2, 2017; 5,623 shares on February 2, 2018. Vested shares will be delivered to the reporting person promptly after the vesting date.
The restricted stock unit was issued pursuant to the Company's 2008 Stock Incentive Plan (as amended and restated as of April 15, 2015).
Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
The restricted stock units vest on May 4, 2018. Vested shares will be delivered to the reporting person on the vesting date.
The restricted stock units vest on December 16, 2018. Vested shares will be delivered to the reporting person on the vesting date.
The restricted stock units vest on May 2, 2019. Vested shares will be delivered to the reporting person on the vesting date.
President, Research and Early Development
/s/ Rupert Vessey _________________________________________
Rupert Vessey
2016-06-23
EX-24.3_663604
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
Know all by these presents, that the undersigned hereby constitutes and appoints
each of Robert J. Hugin, Mark J. Alles and Peter N. Kellogg the undersigned's
true and lawful attorney-in-fact to:
(1) execute for and on behalf of the undersigned, in the undersigned's capacity
as an officer and/or director of Celgene Corporation (the "Company"), Forms 3,
4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934
and the rules thereunder;
(2) do and perform any and all acts for and on behalf of the undersigned which
may be necessary or desirable to complete and execute any such Form 3, 4, or 5,
complete and execute any amendment or amendments thereto, and timely file such
form with the United States Securities and Exchange Commission and any stock
exchange or similar authority; and
(3) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit to,
in the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that each of the foregoing
attorney-in-fact, in serving in such capacity at the request of the undersigned,
is not assuming, nor is the Company assuming, any of the undersigned's
responsibilities to comply with Section 16 of the Securities Exchange Act of
1934.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorney-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of the date written below.
/s/ Rupert Vessey June 20, 2016
Rupert Vessey